Literature DB >> 19574939

Effect of variation in relaxation parameter value on LOR-RAMLA reconstruction of 18F-FDG PET studies.

David Groheux1, Antoine Martineau, Jean-Marc Vrigneaud, Elif Hindie, Georges Baillet, Jean-Luc Moretti.   

Abstract

PURPOSE: We tested the impact of different values of the relaxation parameter lambda (lambda) on contrast and noise in line-of-response row-action maximum likelihood algorithm (LOR-RAMLA) in 18F-fluorodeoxyglucose positron emission tomography (PET)/computed tomography (CT) imaging.
METHODS: Phantom studies were performed on a Gemini XL PET/CT scanner. The NEMA/IEC (National Electrical Manufacturers Association/International Electro technical Commission) torso phantom was used and acquisition data were reconstructed with lambda values ranging from 0.025 to 0.1. Quality of the reconstructed images was evaluated by contrast recovery coefficients and background variability values according to the NEMA NU 2-2001 procedures.
RESULTS: Contrast recovery coefficients and background variability increased significantly when lambda increased. The best noise-versus-resolution trade-off was obtained with lambda in the 0.04-0.06 range. For LOR-RAMLA reconstruction, the manufacturer allows a possible lambda choice from 0.025 to 0.1. We would not advise too small (0.025) or too large (0.1) lambda values which result in too smooth or too noisy images.
CONCLUSION: We determined optimal lambda values in LOR-RAMLA on a Gemini XL PET/CT scanner. Caution is needed when using lambda values out of that range.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19574939     DOI: 10.1097/MNM.0b013e32832ed3cf

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  1 in total

1.  Assessment of cell proliferation in renal cell carcinoma using dual-phase 18F-fluorodeoxyglucose PET/CT.

Authors:  Rei Onishi; Masanori Noguchi; Hayato Kaida; Fukuko Moriya; Katsuaki Chikui; Seiji Kurata; Akihiko Kawahara; Masayoshi Kage; Masatoshi Ishibashi; Kei Matsuoka
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.